Pain Management and Opioids: A Patient-Centered Approach

The curriculum, developed by nationally known experts in pain management, addiction, and opioids, thoughtfully balances the risks and benefits of opioid prescribing, providing the latest insights in this vital healthcare area. It covers many important topics, including understanding the nature and pathophysiology of pain, effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options, managing patients on opioid analgesics, educating patients and caregivers, and addressing opioid use disorder.

Learning Objectives:

At the end of this activity, learners should be able to:

  • Recognize the origin(s) and types of pain as they relate to pain management and opioid use disorder (OUD).
  • Fully assess persons experiencing pain, including risk for OUD.
  • Develop safe and effective pain management plans using nonpharmacologic and pharmacologic (non-opioid or opioid) options.
  • Partner with patients to reduce risks when taking opioid therapy.

Target Audience:

This activity is designed for physicians, physician associates/assistants, and nurse practitioners.

Participation and Credit:

To earn credit for this educational activity, learners must register and fully participate. Before beginning the activity, learners should review the target audience, learning objectives, and author disclosures. Learners are required to engage with the educational content online and complete the activity evaluation. Upon successful completion of these requirements, a certificate will be available as a downloadable link. Learners may print the certificate for their records; however, they may not alter it. For information regarding the applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Unlabeled Use Disclosure:

This activity may include discussion of unlabeled and/or investigational uses of drugs, biologics, or devices, meaning uses not yet approved by the U.S. Food and Drug Administration for the indication discussed. Any such discussion is not intended to promote, endorse, or recommend the use of any product outside its approved labeling. Faculty presenting such content have been instructed to disclose it during their presentation. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Support:

This activity is supported by an independent educational grant from the Opioid Analgesics REMS Program Companies (RPC). Please see www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA). 

Fee:

There is no charge for this activity.

Cultural/Linguistic Competency:

CAFP policy and California state law requires that each learning activity have elements of cultural and linguistic proficiency included in the content. The definition of cultural and linguistic competency is the ability and readiness of health care providers and health organizations to humbly and respectfully demonstrate, effectively communicate, and tailor delivery of care to patients with diverse values, beliefs, identities, and behaviors, in order to meet patients’ social, cultural, and linguistic needs as it relates to patient health. This activity meets these requirements.

Implicit Bias:

CAFP policy and California state law requires that all CME activities comprising a patient care element include either (1) examples of how implicit bias affects perceptions and treatment decisions of physicians and surgeons, leading to disparities in health outcomes and/or (2) strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics. This activity meets these requirements.

Privacy Policy:

The California Academy of Family Physicians (CAFP) is committed to protecting the privacy of its members and customers. CAFP maintains safeguards to store and secure information it has about members and customers. The safeguards may be physical, electronic or procedural. For more information, contact [email protected].

Questions:

For questions regarding the content of this activity or for technical assistance, contact [email protected].

The CAFP has made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education program does not imply endorsement by CAFP of any product or manufacturer identified.

Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.

Copyright:

© 2026 California Academy of Family Physicians. No part of this activity may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.

Course summary

Available credit: 
  • 2.50 AAFP Prescribed
  • 2.50 AMA PRA Category 1 Credit™
Course opens: 
07/15/2026
Course expires: 
03/31/2027
Rating: 
0

Gloria Sanchez, MD, FASAM

Dr. Gloria Sanchez is a Clinical Professor at the David Geffen School of Medicine at UCLA and is board certified in both Family Medicine and Addiction Medicine. After completing her undergraduate degree at Stanford University, she attended the University of Washington School of Medicine. A leader in addiction care and medical education, she helped establish the first dedicated Medications for Addiction Treatment (MAT) clinic within Los Angeles County DHS and serves as Physician Co-Chair of the LA County DHS Substance Use Advisory Committee. Her work focuses on expanding access to evidence-based addiction treatment for underserved communities.

 

Faculty Advisory Panel: 

  • Michael Cheshire, DO, FACOI, FACP, West Virginia University School of Medicine
  • Katherine Galluzzi, DO, CMD, FACOFP, Philadelphia College of Osteopathic Medicine
  • Barbara St. Marie, PhD, AGPCNP, FAANP, FAAN, University of Iowa
  • Arianna Campbell, DMSc, MPH, PA-C, VA, Northern California Health Care System; Bridge
  • Joseph Shega, MD, Vitas Healthcare
  • Tiffany Nguyen, PharmD, AltaMed Health Services Corporation

Disclosures:

None of the Faculty, Faculty Advisors, or Planners for this activity have relevant financial relationships with ineligible companies to disclose.

Disclosure Statements:

The California Academy of Family Physicians (CAFP) requires everyone in control of educational content, including planners, faculty, authors, content reviewers, members of the Committee on Continuing Professional Development (CCPD), and CAFP education staff, to disclose all financial relationships with ineligible companies held during the 24 months before the activity. CAFP excludes owners and employees of ineligible companies from controlling accredited content, except where the ACCME Standards for Integrity and Independence allow. CAFP education staff, with CCPD oversight, review each disclosure, determine which relationships are relevant to the activity's content, and mitigate each relevant relationship before the individual assumes their role. Mitigation may include peer review of content by an individual with no relevant financial relationships, limiting the individual's role to content unrelated to the ineligible company's products, attestation that clinical recommendations reflect the best available evidence and are free of commercial bias, reassigning the topic, or replacing the individual. All relevant financial relationships listed for this activity have been mitigated.

The AAFP has reviewed Pain Management and Opioids: A Patient-Centered Approach and deemed it acceptable for up to 2.50 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 07/15/2026 to 03/31/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

The California Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The California Academy of Family Physicians designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Available Credit

  • 2.50 AAFP Prescribed
  • 2.50 AMA PRA Category 1 Credit™
Please login or register to take this course.